Veraxa Biotech AG - Post de-SPAC ($VRXA) Insider Trading & Smart Money Activity
Veraxa Biotech AG - Post de-SPAC ($VRXA) has 2 insider trades on file. In the last 12 months on the open market, 2 insiders bought ($42.76K) and no insider sold, net +$42.76K.
- Insider buyers (12 mo)
- 2
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- +$42.76K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
VRXA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 1 · $10.06K | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 1 · $32.70K | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All VRXA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Christoph Samuel ZieglerDirector | Buy (Open-market buy) | 30K sh | $32.70K | +378.21% | SEC | Read | ||||
| Insider | Warren HosseinionDirector | Buy (Open-market buy) | 6.02K sh | $10.06K | +0.96% | -10.9% | -30.9% | SEC | — |
1W / 1M / 6M = how VRXA moved from the trade or filing date.
Insider trading in VRXA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Christoph Samuel Ziegler | Director | 1 | +$32.70K | 37.93K | Oct 20, 2026 |
| Warren Hosseinion | Director | 1 | +$10.06K | 634.69K | Sep 10, 2026 |
Frequently asked questions
Are VRXA insiders buying or selling?
Over the last 12 months 2 insiders made 2 open-market purchases worth $42.76K and 0 insiders made 0 open-market sales worth $0, a net +$42.76K.
What is the latest insider trade in VRXA?
Christoph Samuel Ziegler, Director filed a buy (open-market buy) of 30K sh worth $32.70K on Oct 20, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Reply STOP anytime.
SMS Terms
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.